Endocrine Therapy Omission in Estrogen Receptor-Low (1%-10%) Early-Stage Breast Cancer. Choong GM, Hoskin TL, Boughey JC, Ingle JN, et al. J Clin Oncol 2025 Apr 11:JCO2402263. doi: 10.1200/JCO-24-02263.

Read + Share

Amedeo Smart

Independent Medical Education

Choong GM, Hoskin TL, Boughey JC, Ingle JN, et al. Endocrine Therapy Omission in Estrogen Receptor-Low (1%-10%) Early-Stage Breast Cancer. J Clin Oncol 2025 Apr 11:JCO2402263. doi: 10.1200/JCO-24-02263.
PMID: 40215443